Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

Talecris Biotherapeutics Holdings Corp. · Research Triangle Park, NC United States ·(NASDAQ (GM): TLCR)

Company Description

4101 Research Commons 79 T.W. Alexander Dr.
Research Triangle Park, NC
27709
United States (Map)
Phone: 919-316-6300
Fax: 919-316-6316
    Talecris Biotherapeutics Holdings taps into the healing power of blood. The biopharmaceutical company develops protein therapy products (derived from blood plasma) used to treat conditions such as immune deficiency disorders, severe burns, and hemophilia. The plasma proteins help control bleeding and body function, as well as combat infection. Its lead product, Gamunex IGIV, helps in the treatment of immune deficiency conditions and leukemia, and with bone marrow transplant recovery. Its Prolastin product is used to treat emphysema. Talecris Biotherapeutics operates worldwide from offices in North America and Germany. Cerberus Capital Management controls the company. To read the full description, subscribe now.
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

    Key Talecris Biotherapeutics Holdings Corp. Financials

    Company TypePublic - NASDAQ (GM): TLCR

    Headquarters
    Fiscal Year-EndDecember
    Employees2,600

    Talecris Biotherapeutics Holdings Corp. Executives

    21 executives listed for Talecris Biotherapeutics Holdings Corp.'s Research Triangle Park, NC location.
    TitleName & BioContact
    Chairman and CEOLawrence SternNetwork
    SVP OperationsMary KuhnNetwork
    EVP and CFOJohn HansonNetwork

    Competition

    Competitive Landscape for Talecris Biotherapeutics Holdings Corp.
    Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.
    Top Talecris Biotherapeutics Holdings Corp. Competitors
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!